相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study
Yuji Yada et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed
Georgios Schoretsanitis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Epidemiological Impact of Myocarditis
Ainoosh Golpour et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Clinical Utility and Safety of Slower-than-Recommended Titration of Clozapine for Treatment-Resistant Schizophrenia: a Retrospective Cohort Study
Masaru Tsukahara et al.
PSYCHIATRIC QUARTERLY (2021)
Rapid Titration and Decreased Clozapine ClearanceMay Help Explain Five Cases of Clozapine-Induced Myocarditis in a New York Hospital
Jose de Leon et al.
PSYCHOSOMATICS (2020)
Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic Acid
Jose de Leon
THERAPEUTIC DRUG MONITORING (2020)
Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy
Dan Siskind et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine Treatment
Can-Jun Ruan et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Dose and safety concerns of clozapine: Worldwide package inserts need revisions
Jose de Leon et al.
SCHIZOPHRENIA RESEARCH (2020)
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia
A. G. Villasante-Tezanos et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
Jose de Leon et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?
Can-Jun Ruan et al.
PHARMACOGENOMICS (2020)
Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study
Satish Suhas et al.
SCHIZOPHRENIA RESEARCH (2020)
Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview
Jose de Leon et al.
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)
Clozapine is strongly associated with the risk of pneumonia and inflammation
Jose de Leon et al.
GENERAL PSYCHIATRY (2020)
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes
Sam Mostafa et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Clozapine-induced myocarditis: A rare adverse drug reaction not to ignore
Rim Masmoudi et al.
THERAPIE (2019)
Clozapine and cardiotoxicity - A guide for psychiatrists written by cardiologists
Rishi K. Patel et al.
PSYCHIATRY RESEARCH (2019)
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
Rika Wakao et al.
DRUG SAFETY (2019)
A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring
Anil Yagcioglu et al.
PSYCHIATRY RESEARCH (2019)
Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2019)
Exploring the Prevalence of Clozapine Phenotypic Poor Metabolizers in 4 Asian Samples They Ranged Between 2% and 13%
Can-Jun Ruan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Clozapine Metabolism in East Asians and Caucasians A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review
Can-Jun Ruan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
A systematic review of clozapine-induced myocarditis
Brandi L. Bellissima et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Jessica W. Y. Yuen et al.
FRONTIERS IN NEUROSCIENCE (2018)
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review
Kristen N. Knoph et al.
SCHIZOPHRENIA RESEARCH (2018)
Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study
C. Rohde et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Tracing the peopling of the world through genomics
Rasmus Nielsen et al.
NATURE (2017)
Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy
Nitin Chopra et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2016)
Some Thoughts on Pharmacovigilance and Postmarketing Surveillance
Richard I. Shader
CLINICAL THERAPEUTICS (2016)
Clozapine Underutilization in the Treatment of Schizophrenia How Can Clozapine Prescription Rates Be Improved?
Jan P. A. M. Bogers et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Stephane Heymans et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Systematic Review of Clozapine Cardiotoxicity
Martina Curto et al.
CURRENT PSYCHIATRY REPORTS (2016)
Clozapine-induced myocarditis: prescribe safely but do prescribe
O. Freudenreich
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations
J. de Leon et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Clozapine-induced myocarditis, a widely overlooked adverse reaction
K. J. Ronaldson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Heterogeneity of clozapine-associated myocarditis: An opportunity for novel preventing strategies
Trino Baptista et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999-2014
Xiang-qing Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Clozapine-induced myocarditis: Separating the wheat from the chaff
Karl Winckel et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'
P. F. J. Schulte et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
A systematic review of clozapine induced cardiomyopathy
Mohammed Alawami et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Clozapine-induced cardiomyopathy: A first case in Japan
Yuka Kikuchi et al.
SCHIZOPHRENIA RESEARCH (2013)
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
G. Niklas Noren et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: Results from a 12-week, flexible dose study using raters masked to antipsychotic choice
Taro Kishi et al.
ASIAN JOURNAL OF PSYCHIATRY (2013)
Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
Dan Cohen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A case-control study
Kathlyn J. Ronaldson et al.
SCHIZOPHRENIA RESEARCH (2012)
Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Domenico De Berardis et al.
CURRENT DRUG SAFETY (2012)
A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls
Kathlyn J. Ronaldson et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
Adverse Events in Randomized Trials Neglected, Restricted, Distorted, and Silenced
John P. A. Ioannidis
ARCHIVES OF INTERNAL MEDICINE (2009)
The Incidence and Characteristics of Clozapine-Induced Fever in a Local Psychiatric Unit in Hong Kong
Joseph Pui-yin Chung et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2008)
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database
A. Bate et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Serious adverse drug events reported to the food and drug administration, 1998-2005
Thomas J. Moore et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans
Roza Ghotbi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The history of clozapine and its emergence in the US market: a review and analysis
John Crilly
HISTORY OF PSYCHIATRY (2007)
Monitoring the safe use of clozapine - A consensus view from Victoria, Australia
Michael Berk et al.
CNS DRUGS (2007)
Clozapine-associated myocarditis - A review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003
Steven J. Haas et al.
DRUG SAFETY (2007)
Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine
PM Wehmeier et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
Adverse cardiac effects associated with clozapine
DB Merrill et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Clozapine-induced fevers and 1-year clozapine discontinuation rate
JC Tham et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Myocarditis related to clozapine treatment
S Hägg et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
DM Coulter et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
分享论文
